While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Recursion Pharmaceuticals has reported updated data from its ELUCIDATE & TUPELO trials, but the stock has failed to mount a ...

AI models can process thousands of factors simultaneously, including demand signals across multiple items, macroeconomic ...

The evidence shows that, under controlled conditions, LLM judges can align closely with clinician judgments on concrete, ...

Gordon died in a hotel room with a copy of his favorite children’s book, Goodnight Moon, at his side. Inside, he left ...

Information pervades the universe, yet means nothing. Meaning emerged when matter organized into systems that could ...

Welcome to the era of "Action Drift," where your agents are negotiating trades your CRO won’t understand for another six ...

Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the market? This article walks through what the current numbers may be telling ...

For the past week or so, I’ve been working with a digital assistant that knows my name, my preferences for my morning routine, how I like to use Notion and Todoist, but which also knows how to control ...

Skip one-click backup apps. This rsync script gives you full control over what gets saved and when, plus logs and a few hard-won lessons.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...